NCT05641883尚未招募不适用
A Prospective Pilot Study of the Combination of CardiaMend and Amiodarone for the Prevention of Postoperative Atrial Fibrillation (POAF) in Patients Undergoing Isolated Coronary Artery Bypass Grafting or Isolated Valve Surgery
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 30
- 主要终点
- Incidence of POAF
研究概览
简要总结
The principal purpose of this investigator-initiated trial is to study the use of the CardiaMend device soaked in the anti-arrhythmic drug amiodarone, and how it may decrease the development of atrial fibrillation in patients that have undergone a coronary artery bypass surgery, or isolated valve surgery.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Prevention
- 盲法
- None
入排标准
- 年龄范围
- 21 Years 至 85 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Aged 21-85 years
- •Able to provide written informed consent, understand and be willing to comply with study-related procedures.
- •Scheduled to undergo open-chest cardiac surgery via complete median sternotomy for coronary artery bypass graft (CABG), or isolated valve repair/replacement.
- •Inclusionary valve repair/replacement procedures with the primary reason for surgery inclusive of aortic valve repair/replacement or mitral valve repair/replacement.
- •Left atrial appendage (LAA) procedures are allowed if CABG and/or valve repair or replacement is the qualifying surgical procedure, but is not a qualifying surgical procedure on its own.
- •In sinus rhythm at the time of consultation and on a previous EKG, or no history of atrial fibrillation (note: continuous ECG monitoring for 48 hours is not required)
排除标准
- •Unable to give voluntary written informed consent, is unlikely to cooperate or is legally incompetent, including subjects who are institutionalized by court or official order, or in a dependency relationship with testing center or investigator.
- •Any condition which could interfere with the subject's ability to comply with the study.
- •Ongoing participation in an interventional clinical study or during the preceding 30 days.
- •Female subjects who are pregnant, breastfeeding, were pregnant within the last three months or are planning a pregnancy during the course of the study.
- •Active skin or deep infection at the site of implantation.
- •History of chronic wounds or wound-healing disorders.
- •Known connective tissue diseases (e.g. Ehlers-Danlos syndrome, Epidermolysis bullosa, Marfan syndrome, Osteogenesis imperfecta).
- •Immune-suppressed subjects, immune-deficiency subjects (properly managed diabetes mellitus is not an exclusion criterion).
- •The subject has an implantable cardiac device (i.e., cardiac resynchronization therapy devices with and without defibrillator capabilities (CRTs and CRT-Ds), implantable cardioverter-defibrillators (ICD) and pacemakers).
- •Known history of atrial fibrillation (in any form including paroxysmal atrial fibrillation).
- •History of ablation for atrial fibrillation.
- •Patients already receiving amiodarone as a treatment for atrial fibrillation or ventricular arrhythmias during the procedure.
- •Disease of the left pleura, previous intervention in the left pleural space, or chest deformity.
- •Subjects with end-stage chronic-renal disease / dialysis.
- •Subjects with heart failure (BNP>1000), low ejection fraction (<35%), end stage renal disease (on dialysis or creatinine >1.8).
- •STS risk >5.5% for 30 day mortality.
- •Patients electing to receive an ablative procedure for atrial fibrillation.
结局指标
主要结局
Incidence of POAF
时间窗: 5 days
Incidence of POAF up to patient discharge as defined as atrial fibrillation/flutter (AF) after OR exit that lasted longer than one hour, or lasted less than one hour but required medical or procedural intervention.
次要结局
- Time until discharge(5 days)
研究者
Robert Saeid Farivar, MD
Medical Director of Cardiothoracic Surgery
Saint Alphonsus Regional Medical Center
相似试验
已完成
4 期
Prevention of Post-OP AFib Using Combination of CardiaMend and AmiodaronePost Operative Atrial FibrillationNCT05681182WakeMed Health and Hospitals30
已完成
2 期
A Dose-finding Study of OPC-41061 in Treatment of Cardiac Edema (Congestive Heart Failure)EdemaHeart Failure, CongestiveNCT00234104Otsuka Pharmaceutical Co., Ltd.122
已完成
早期 1 期
A Clinical Trial for the Safety and Efficacy of CD-801 in Patients With Advanced Hepatocellular CarcinomaAdvanced Hepatocellular CarcinomaNCT06092112Shanghai Changzheng Hospital2
已完成
不适用
Cardiopulmonary Exercise Testing and Preoperative Risk StratificationAnaesthesiaCritical IllnessColorectal CancerNCT00737828University College London Hospitals228
已完成
不适用
A Patient-Centered Communication Tool (UR-GOAL) Versus Usual Care for Older Patients With Acute Myeloid Leukemia, Their Caregivers, and Their OncologistsAcute Myeloid LeukemiaNCT05335369University of Rochester161